QT Imaging CEO Advocates for Early Breast Cancer Detection at Harvard Gala — QT Imaging Holdings, Inc.

Event summary

QT Imaging CEO Dr. Raluca Dinu participated in a panel at the inaugural Shiftmakers Gala at Harvard University on March 27, 2026.
The event was hosted by The Shift, a women's media platform backed by Gloria Steinem.
QT Imaging's Breast Acoustic CT™ technology was highlighted as a solution for detecting breast cancer in women with dense breast tissue.
The company's advances in breast imaging will be featured in an upcoming article in The Shift.

The big picture

QT Imaging's participation in the Shiftmakers Gala underscores the growing focus on women's health and early cancer detection. The event highlights the company's strategic positioning in a market where traditional mammography falls short for women with dense breast tissue. With backing from prominent figures like Gloria Steinem and media coverage in platforms like Fortune and Cosmopolitan, QT Imaging is well-positioned to capitalize on the increasing attention to women's health innovations.

What we're watching

Market Penetration: How QT Imaging will leverage media attention to accelerate adoption of its radiation-free imaging technology.
Regulatory Dynamics: Whether increased national attention on women’s health will lead to favorable regulatory shifts for QT Imaging’s technology.
Competitive Positioning: The pace at which QT Imaging can differentiate itself in a market dominated by traditional mammography solutions.